Co-Authors
This is a "connection" page, showing publications co-authored by Paul Verweij and Roger Brüggemann.
Connection Strength
3.672
-
The Challenge of Managing COVID-19 Associated Pulmonary Aspergillosis. Clin Infect Dis. 2021 12 06; 73(11):e3615-e3616.
Score: 0.983
-
Itraconazole or Amphotericin B for Talaromycosis. N Engl J Med. 2017 10 05; 377(14):1402-1403.
Score: 0.736
-
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021 08; 47(8):819-834.
Score: 0.238
-
COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion. Lancet Respir Med. 2021 07; 9(7):795-802.
Score: 0.237
-
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020 Aug; 46(8):1524-1535.
Score: 0.222
-
Diagnosing COVID-19-associated pulmonary aspergillosis. Lancet Microbe. 2020 Jun; 1(2):e53-e55.
Score: 0.220
-
Clinical Pharmacokinetics and Pharmacodynamics of Micafungin. Clin Pharmacokinet. 2018 03; 57(3):267-286.
Score: 0.189
-
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs. J Antimicrob Chemother. 2018 Jan 01; 73(1):134-142.
Score: 0.187
-
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs. J Antimicrob Chemother. 2018 01 01; 73(1):263.
Score: 0.187
-
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients. Clin Pharmacokinet. 2017 10; 56(10):1197-1206.
Score: 0.184
-
Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations. Antimicrob Agents Chemother. 2017 09; 61(9).
Score: 0.183
-
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021 06; 21(6):e149-e162.
Score: 0.057
-
The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole-resistance. A nationwide survey and rationale for the DB-MSG 002 study protocol. Mycoses. 2018 Sep; 61(9):656-664.
Score: 0.049